Form 4: F5 EVP Sells 386 Shares Under 10b5-1 Plan
Insider Transaction Report
Angelique M. Okeke, EVP and General Counsel of F5, Inc., sold 386 shares of common stock for $278.32 per share on February 10, 2026, pursuant to a pre-arranged trading plan.
Summary
- Angelique M. Okeke, Executive Vice President and General Counsel of F5, Inc. (FFIV), reported a sale of common stock.
- The transaction involved the disposition of 386 shares of F5, Inc. common stock.
- The shares were sold at a price of $278.32 per share.
- The transaction occurred on February 10, 2026.
- This sale was executed under a Rule 10b5-1 trading plan established on October 30, 2025.
- Following this transaction, Ms. Okeke beneficially owns 1,874 shares of F5, Inc. common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction executed under a pre-arranged 10b5-1 plan, which typically minimizes its interpretative significance regarding the company's immediate prospects.
Negatives
- An executive selling shares, even under a pre-arranged plan, could be perceived negatively by some investors as it reduces their direct stake in the company.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider sales, especially those executed under a Rule 10b5-1 plan, are common occurrences in the technology sector. These plans allow executives to sell shares systematically over time to avoid accusations of trading on material non-public information. While a sale reduces an executive's direct holdings, it does not necessarily signal a negative outlook for the company, particularly when pre-scheduled.
Stakeholder Impact
- Shareholders may note the reduction in direct ownership by a key executive, though the 10b5-1 plan context mitigates concerns regarding the company's immediate prospects.
Key Dates
| Date | Description |
|---|---|
| 10/30/2025 | Date Rule 10b5-1 trading plan was established. |
| 02/10/2026 | Date of common stock transaction (sale). |
| 02/11/2026 | Date Form 4 was signed and filed. |
Recommendation
holdThe sale by a key executive, while executed under a pre-planned 10b5-1 program, is a routine event that does not provide new fundamental information about F5, Inc.'s operational performance or strategic direction. Investors should maintain their current position and look for more substantive financial or operational updates for investment decisions.
Keywords
F5 Inc, FFIV, Insider Sale, Form 4, Angelique M. Okeke, Executive Stock Sale, 10b5-1 Plan, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.